The aim of this study was to evaluate the feasibility of first-trimester biochemical screening for trisomy 18, by using pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (hCG) in combination with maternal age. Maternal serum levels of PAPP-A and free beta-hCG
Evaluation of pregnancy outcome in euploid fetuses with a screen positive second trimester maternal serum screen for trisomy 18
โ Scribed by Calla Holmgren; Alexandra Grosvenor; Kristy Nelson; Nancy Rose
- Book ID
- 113431737
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 102 KB
- Volume
- 195
- Category
- Article
- ISSN
- 1097-6868
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A retrospective study on screening methods for fetal trisomy 18 has been carried out in two different laboratories using the serum parameters: total human chorionic gonadotropin (hCG), unconjugated oestriol (uE3), and -fetoprotein (AFP) in different combinations and in single marker protocols. Labor
In a group of 26 524 control pregnancies and a group of 3728 pregnancies affected by one or more of the pregnancy complications of low birthweight, intra-uterine growth restriction (IUGR), preterm delivery and stillbirth, I have compared the relative risk of occurrence of these complications in preg